Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Toronto Dominion Bank

Toronto Dominion Bank lowered its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 21.4% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 329,469 shares of the pharmacy operator’s stock after selling 89,450 shares during the quarter. Toronto Dominion Bank’s holdings in Walgreens Boots Alliance were worth $3,985,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Iron Horse Wealth Management LLC grew its holdings in shares of Walgreens Boots Alliance by 162.5% during the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 1,300 shares during the last quarter. Pineridge Advisors LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth about $26,000. Blue Trust Inc. increased its holdings in shares of Walgreens Boots Alliance by 87.0% in the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 1,081 shares during the period. Continuum Advisory LLC lifted its position in Walgreens Boots Alliance by 71.2% in the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 1,020 shares during the last quarter. Finally, 1832 Asset Management L.P. boosted its stake in Walgreens Boots Alliance by 282.1% during the 4th quarter. 1832 Asset Management L.P. now owns 1,219 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 900 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Truist Financial reduced their price objective on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a research report on Friday, June 28th. JPMorgan Chase & Co. lowered their target price on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research note on Friday, August 30th. Bank of America reduced their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. Royal Bank of Canada lowered their price objective on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating on the stock in a research note on Tuesday, July 2nd. Finally, TD Cowen dropped their target price on Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating on the stock in a report on Thursday, September 12th. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus target price of $14.73.

Walgreens Boots Alliance Trading Up 6.3 %

Shares of WBA opened at $9.06 on Monday. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance, Inc. has a 1-year low of $8.22 and a 1-year high of $27.05. The stock has a market capitalization of $7.82 billion, a P/E ratio of -1.34, a P/E/G ratio of 0.97 and a beta of 0.70. The business’s 50-day moving average price is $10.00 and its 200 day moving average price is $14.23.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The firm had revenue of $36.40 billion for the quarter, compared to analyst estimates of $35.94 billion. During the same quarter in the prior year, the firm earned $1.00 EPS. The firm’s revenue was up 2.8% compared to the same quarter last year. Analysts expect that Walgreens Boots Alliance, Inc. will post 2.86 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st were paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.04%. The ex-dividend date of this dividend was Wednesday, August 21st. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently -14.84%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.